The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population

被引：2

作者：

Ng, Wai-Yoong ^{[1
]}

Lim, Daniel Yan-Zheng ^{[2
,3
]}

Tan, Si-Yu ^{[1
]}

Chang, Jason Pik-Eu ^{[4
]}

Krishnamoorthy, Thinesh Lee ^{[4
]}

Lim, Chee-Hooi ^{[4
]}

Tan, Damien Meng-Yew ^{[4
]}

Ekstrom, Victoria Sze-Min ^{[4
]}

Goh, George Boon-Bee ^{[4
]}

Cheah, Mark Chang-Chuen ^{[4
]}

Kumar, Rajneesh ^{[4
]}

Yeo, Chin-Pin ^{[1
]}

Tan, Chee-Kiat ^{[4
,5
]}

机构：

[1] Singapore Gen Hosp, Dept Clin Pathol, Singapore, Singapore

[2] Singapore Gen Hosp, Med Board, Hlth Serv Res Unit, Singapore, Singapore

[3] Duke NUS Med Sch, Med Acad Clin Programme, Singapore, Singapore

[4] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore

[5] Academia, Dept Gastroenterol & Hepatol, Level 3,20 Coll Rd, Singapore 169856, Singapore

来源：

ANNALS ACADEMY OF MEDICINE SINGAPORE | 2023年 / 52卷 / 02期

关键词：

DES-GAMMA-CARBOXYPROTHROMBIN; ALPHA-FETOPROTEIN;

D O I：

10.47102/annals-acadmedsg.2022351

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：108 / 110

页数：3

共 50 条

[21] Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development
Caviglia, Gian Paolo
Abate, Maria Lorena
Troshina, Giulia
Carucci, Patrizia
Rolle, Emanuela
Risso, Alessandra
Burlone, Michela Emma
Albe, Alice
Crevola, Martina
Musso, Emma Clara
Rosso, Chiara
Armandi, Angelo
Olivero, Antonella
Minisini, Rosalba
Saracco, Giorgio Maria
Bugianesi, Elisabetta
Pirisi, Mario
Ciancio, Alessia
Gaia, Silvia
BIOLOGY-BASEL, 2023, 12 (01):
[22] PIVKA-II
建石良介
韩少良
日本医学介绍, 2005, (02) : 51 - 52
[23] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
Honglei Feng
Bole Li
Ze Li
Qian Wei
Li Ren
BMC Cancer, 21
[24] Usefulness of DCP assay method (PIVKA-II IRMA "Daiichi") for hepatocellular carcinoma
Takahashi, Y
Shinbata, H
Yagi, S
Narimatsu, T
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1204 - 1204
[25] Clinical significance of PIVKA-II levels after liver transplantation for hepatocellular carcinoma
Villalba, F.
Alconchel, F.
Saenz, L.
Sanchez, M. I.
Ferreras, D.
Cascales, P.
Robles, R.
Sanchez-Bueno, F.
Ramirez, P.
TRANSPLANTATION, 2022, 106 (8S) : 168 - 168
[26] Usefulness of PIVKA-II after Living Donor Liver Transplantation for Hepatocellular Carcinoma
Park, Min-Su
Lee, Kwang-Woong
Choi, YoungRok
Suh, Suk-Won
Lee, Jeong-Moo
Yi, Nam-Joon
Suh, Kyung-Suk
LIVER TRANSPLANTATION, 2014, 20 : S184 - S184
[27] Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
An, Shu
Zhan, Xiaoxia
Liu, Min
Li, Laisheng
Wu, Jian
DIAGNOSTICS, 2023, 13 (08)
[28] The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Basile, U.
Miele, L.
Napodano, C.
Ciasca, G.
Gulli, F.
Pocino, K.
De Matthaeis, N.
Liguori, A.
De Magistris, A.
Marrone, G.
Biolato, M.
Marino, M.
Di Giacinto, F.
Gasbarrini, A.
Grieco, A.
Rapaccini, G. L.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) : 12675 - 12685
[29] Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma
Villalba-Lopez, Francisco
Saenz-Mateos, Luis Francisco
Sanchez-Lorencio, Maria Isabel
De La Orden-Garcia, Virginia
Alconchel-Gago, Felipe
Cascales-Campos, Pedro Antonio
Garcia-Bernardo, Carmen
Noguera-Velasco, Jose Antonio
Baroja-Mazo, Alberto
Ramirez-Romero, Pablo
SCIENTIFIC REPORTS, 2023, 13 (01)
[30] Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma
Francisco Villalba-López
Luis Francisco Sáenz-Mateos
Maria Isabel Sánchez-Lorencio
Virginia De La Orden-García
Felipe Alconchel-Gago
Pedro Antonio Cascales-Campos
Carmen García-Bernardo
José Antonio Noguera-Velasco
Alberto Baroja-Mazo
Pablo Ramírez-Romero
Scientific Reports, 13

← 1 2 3 4 5 →